Heslop, H E <br/><br/>
Response of steroid-resistant graft-versus-host disease to lymphoblast antibody CBL1.  [electronic resource] 

 -  Lancet (London, England)  Sep 1995 
 - 805-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0140-6736 
<br/><br/><label>Standard No.: </label>10.1016/s0140-6736(95)91621-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antigens, Differentiation--immunology<br/>B-Lymphocytes--immunology<br/>Child<br/>Child, Preschool<br/>Drug Resistance<br/>Female<br/>Forecasting<br/>Glycolipids--immunology<br/>Graft vs Host Disease--classification<br/>Humans<br/>Immunocompromised Host<br/>Immunoglobulin M--therapeutic use<br/>Infant<br/>Killer Cells, Natural--immunology<br/>Lymphocyte Activation--immunology<br/>Male<br/>Membrane Lipids--immunology<br/>Methylprednisolone--therapeutic use<br/>Remission Induction<br/>T-Lymphocytes--immunology<br/>Transplantation Immunology